Review
Jul 2026
Vitamin B12-mediated microglial immunometabolic reprogramming: A novel mechanistic insight into diabetes-associated cognitive impairment.
Current evidence linking VB12 deficiency to microglial immunometabolic remodeling in diabetes-associated cognitive impairment is summarized and the therapeutic potential of targeting VB12 metabolism and gut microbial ecology for preventing diabetes-related cognitive decline is discussed.
Xin Zhang, Jing Li, Yu An et al.
· Progress in Neuro-psychophar... · 0 citations